Skip to main content
Caplight Logo









ABLE Labs

ABLE Labs

Private
IncheonHealthcare & Life Scienceshttps://ablelabsinc.com/

Last Round

Series A

Aug 31, 2026

Total Funding Raised

$11M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

ABLE Labs is a biotechnology company that develops lab automation robotics and liquid handling systems designed to streamline biological research workflows.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Industrial Robotics, Low-Code/No-Code, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

liquid handling robotlab automationno-code softwarepipetting robotlaboratory roboticsself-driving labbiotech equipmentworkflow automationmolecular diagnosticsproof of conceptPoClab techautomated science

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ABLE Labs Comparables

Compare ABLE Labs with similar companies based on industry and business-model similarity.

ABLE Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flow Robotics A/S
85%
XImaging
78%
Opentrons
77%

ABLE Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 31, 2026
Pre SeedAug 17, 2022

Key People

Founding team and executive leadership

Sang Shin

Chief Executive Officer

Executive Team

ABLE Labs Investors

Notable investors and investment history

ABLE Labs investors
InvestorRounds
Now IB CapitalSeries A
FuturePlaySeries A, Pre Seed
Capstone Partners KoreaSeries A
Mirae Asset Venture InvestmentPre Seed
Magna InvestmentSeries A
Industrial Bank of KoreaSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    $9M round with participation from FuturePlay and Magna Investment.

  • May 11, 2026

    Monthly visitors increased 78% MoM, reaching 7.2K.

ABLE Labs Filings

Explore SEC and related filing metadata, where available.

ABLE Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ABLE Labs's valuation, stock price, and market status.

Is ABLE Labs a public or private company?

ABLE Labs is a private company.

What is the current stock price of ABLE Labs?

ABLE Labs is a private company, so its shares have no public market price. Caplight tracks ABLE Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ABLE Labs worth (valuation)?

Valuation information for ABLE Labs is not publicly available.

Can I buy ABLE Labs stock?

ABLE Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ABLE Labs's last funding round?

ABLE Labs's most recent funding round was Series A on August 31, 2026.

Who are the main investors in ABLE Labs?

Key investors in ABLE Labs include Now IB Capital, FuturePlay, Capstone Partners Korea, Mirae Asset Venture Investment, Magna Investment.

Will ABLE Labs IPO soon?

No public IPO plans have been announced for ABLE Labs.

How can I track ABLE Labs secondary market activity?

Caplight tracks bids, offers, and trades in ABLE Labs's shares on secondary markets.

Firmographic Details

HeadquartersIncheon
Employee Range16
Year Founded2021
Last FundingAug 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?